Product Name

  • Name

    Beta-cyclodextrin

  • EINECS 231-493-2
  • CAS No. 7585-39-9
  • Article Data79
  • CAS DataBase
  • Density 1.624 g/cm3
  • Solubility 18.5 g/L (25 °C) in water
  • Melting Point 298-300 °C
  • Formula C42H70O35
  • Boiling Point 1578.5oC at 760 mmHg
  • Molecular Weight 1135
  • Flash Point 908.5oC
  • Transport Information
  • Appearance white powder
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 7585-39-9 (Beta-cyclodextrin)
  • Hazard Symbols IrritantXi
  • Synonyms Schardinger b-dextrin;Stereoisomer of5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol;beta-Cycloheptaamylose;β-Cyclodextrin;beta cyclodextrin;Cycloheptaamylose(7CI);BW 7;BW 7(polysaccharide);Betadex;Cavatex W 7MCT;Celdex B100H;Celdex B 100z;Cibatex OC-CLD;Cycloheptaglucan;Cycloheptaglucosan;Dextrin, b-cyclo;Dexy Pearl 100;Kleptose;NSC 269471;NSC 314334;Rindex B;Ringdex B;RingdexBL;
  • PSA 554.05000
  • LogP -15.23060

Synthetic route

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; water regioselective reaction;100%
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

Mono-3A,6A-anhydrocyclomaltoheptaose
104867-20-1

Mono-3A,6A-anhydrocyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 11h;A 87.9%
B 8.2%
mono-6-deoxy-6-formyl-β-cyclodextrin
159496-21-6

mono-6-deoxy-6-formyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium tetrahydroborate In water for 24h; Ambient temperature;72%
With sodium tetrahydroborate In methanol; water for 1h;
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With ammonia In water at 60℃; for 5h; Product distribution / selectivity;A 70%
B 30%
C42H70O35*C37H47N3(2+)*2Br(1-)
141484-64-2

C42H70O35*C37H47N3(2+)*2Br(1-)

A

C37H47N3(2+)*2Br(1-)
141484-62-0

C37H47N3(2+)*2Br(1-)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water-d2 at 30℃; Equilibrium constant; Thermodynamic data; other temperatures; free energy of activation at 70 deg C;
C42H70O35*C6H13N3OS

C42H70O35*C6H13N3OS

A

3-t-butyl-1-methyl-1-nitrosothiourea
95598-14-4

3-t-butyl-1-methyl-1-nitrosothiourea

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With acetate buffer at 37℃; Rate constant; dissociation constant and catalyzed rate constant of the inclusion complex is determined;
C42H70O35*C12H14N2
114987-36-9

C42H70O35*C12H14N2

A

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

B

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl
25128-26-1

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
prostacyclin*β-cyclodextrin
77164-53-5

prostacyclin*β-cyclodextrin

A

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid
58962-34-8

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C21H34O5
69377-76-0

C42H70O35*C21H34O5

A

6-keto-PGF1α methyl ester
63557-55-1

6-keto-PGF1α methyl ester

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C15H17BrNO(1+)*Br(1-)
80800-15-3

C42H70O35*C15H17BrNO(1+)*Br(1-)

A

trimethylammonium bromide
80214-62-6

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C19H25BrNO(1+)*Br(1-)
80800-16-4

C42H70O35*C19H25BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-16-2

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C24H35BrNO(1+)*Br(1-)
80822-21-5

C42H70O35*C24H35BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-17-3

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C6H15NO3

C42H70O35*C6H15NO3

A

triethanolamine
102-71-6

triethanolamine

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; further temperatures;
C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

A

sodium 4-pyren-1-ylbutyrate
63442-80-8

sodium 4-pyren-1-ylbutyrate

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
2C42H70O35*C20H15O2(1-)*Na(1+)

2C42H70O35*C20H15O2(1-)*Na(1+)

A

C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-bromo-6-deoxy)-β-cyclodextrin
53784-83-1

heptakis(6-bromo-6-deoxy)-β-cyclodextrin

Conditions
ConditionsYield
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 0 - 80℃; for 15h;100%
With tetraethylammonium bromide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;97%
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃;95%
allyl bromide
106-95-6

allyl bromide

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin
141126-40-1

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin

Conditions
ConditionsYield
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide at 60℃; for 2.5h;
Stage #2: allyl bromide In N,N-dimethyl-formamide at 60℃; for 16h; Further stages.;
100%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 5℃; for 1h;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 0 - 20℃;
98%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; Inert atmosphere;
88%
With sodium hydride In N,N-dimethyl-formamide at 20 - 23℃; for 13h;49%
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-CD-fenchene

β-CD-fenchene

Conditions
ConditionsYield
Stage #1: fenchene; β‐cyclodextrin In 1,4-dioxane; water at 20℃; for 0.25h;
Stage #2: In water at 20 - 75℃;
100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
benzyl chloride
100-44-7

benzyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose
129318-82-7, 130322-65-5, 130322-67-7

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose

Conditions
ConditionsYield
With sodium hydride In dimethyl sulfoxide at 20℃; for 22h; Inert atmosphere; Schlenk technique;99%
With sodium hydride In dimethyl sulfoxide; mineral oil at 20℃; Inert atmosphere;96%
With sodium hydride In dimethyl sulfoxide95%
3,4,5,6-tetrahydro-2H-pyran-2-one
542-28-9

3,4,5,6-tetrahydro-2H-pyran-2-one

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

Conditions
ConditionsYield
at 100℃; for 48h;98%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

per-O-acetylated β-cyclodextrin

per-O-acetylated β-cyclodextrin

Conditions
ConditionsYield
With copper(II) perchlorate hexahydrate In neat (no solvent) at 20℃; for 0.25h; Inert atmosphere;98%
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 0.25h; Inert atmosphere; regioselective reaction;97%
With iodine at 20℃; Neat (no solvent); Air atmosphere;96%
C20H20N2*2ClH

C20H20N2*2ClH

ClH*C17H16N4
1427351-20-9

ClH*C17H16N4

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

Conditions
ConditionsYield
In water at 60℃; for 0.5h; Huisgen Cycloaddition;97%
2CBP·2Cl

2CBP·2Cl

N-(3,5-dimethoxybenzyl)propargylammonium chloride

N-(3,5-dimethoxybenzyl)propargylammonium chloride

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

Conditions
ConditionsYield
In water at 20℃; for 1h;97%
1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H70O35*C21H29NO3*C2H2O4

C42H70O35*C21H29NO3*C2H2O4

Conditions
ConditionsYield
In ethanol; water97%
Conditions
ConditionsYield
In ethanol; water at 25℃;96.3%
4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-cyclodextrin

β-cyclodextrin

Conditions
ConditionsYield
In ethanol; water at 50 - 55℃;96.3%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin
123155-03-3

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin

Conditions
ConditionsYield
With pyridine at 20℃; for 18.6667h; Inert atmosphere;96%
With pyridine 1) ice bath, 6.5 h; 2) 18 h, rt;95%
With pyridine90%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

peracetylated β-cyclodextrin
23739-88-0

peracetylated β-cyclodextrin

Conditions
ConditionsYield
With iodine at 20℃; for 24h; neat (no solvent);96%
With 1,4-diaza-bicyclo[2.2.2]octane at 55℃; for 4.5h; Neat (no solvent);96%
With lithium perchlorate for 50h; Heating;93%

beta-Cyclodextrin Specification

The beta-Cyclodextrin, with the CAS registry number 7585-39-9, has the systematic name Cycloheptapentylose. Its molecular formula is C42H70O35 and its classification codes are Carcinogens; Food additives; Noxae; Pharmaceutic aid [sequestering agent]; Reproductive Effect. Moreover, it belongs to the product categories Industrial / Fine Chemicals; Biochemistry; Cyclodextrins; Functional Materials; Macrocycles for Host-Guest Chemistry; Oligosaccharides; Sugars; Dextrins、Sugar & Carbohydrates; Cosmetic Ingredients & Chemicals.

Other characteristics of the beta-Cyclodextrin can be summarised as followings: (1)ACD/LogP: -13.96; (2)# of Rule of 5 Violations: 3; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 35; (8)#H bond donors: 21; (9)#Freely Rotating Bonds: 28; (10)Polar Surface Area: 554.05 Å2; (11)Index of Refraction: 1.591; (12)Molar Refractivity: 236.118 cm3; (13)Molar Volume: 698.755 cm3; (14)Polarizability: 93.605×10-24cm3; (15)Surface Tension: 73.866 dyne/cm; (16)Density: 1.624 g/cm3; (17)Flash Point: 885.873 °C; (18)Enthalpy of Vaporization: 267.98 kJ/mol; (19)Boiling Point: 1541.179 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.

When you are using this chemical, please be cautious about it as the following: This chemical is irritating to eyes, respiratory system and skin. You should wear suitable protective clothing if you use it. In case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure: 
1.SMILES: C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O
2.InChI: InChI=1/C42H70O35/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51/h8-63H,1-7H2/t8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m1/s1
3.InChIKey: WHGYBXFWUBPSRW-FOUAGVGXBA

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 330mg/kg (330mg/kg)   "Proceedings of the International Symposium on Cyclodextrins, 1st, 1981," Szejtli, J., ed., Hingham, MA, Kluwer Academic Pub., 1982Vol. 1, Pg. 109, 1982.
mouse LD50 oral > 12500mg/kg (12500mg/kg)   Pesticide Science. Vol. 11, Pg. 134, 1980.
mouse LD50 subcutaneous 412mg/kg (412mg/kg)   "Proceedings of the International Symposium on Cyclodextrins, 1st, 1981," Szejtli, J., ed., Hingham, MA, Kluwer Academic Pub., 1982Vol. 1, Pg. 109, 1982.
rat LD50 intraperitoneal 356mg/kg (356mg/kg)   "Proceedings of the International Symposium on Cyclodextrins, 1st, 1981," Szejtli, J., ed., Hingham, MA, Kluwer Academic Pub., 1982Vol. 1, Pg. 109, 1982.
rat LD50 intravenous 1008mg/kg (1008mg/kg)   American Journal of Pathology. Vol. 83, Pg. 367, 1976.
rat LD50 oral 18800mg/kg (18800mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 26, Pg. 287, 1983.
rat LD50 subcutaneous 3700mg/kg (3700mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 26, Pg. 287, 1983.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View